Wellcome Trust Sanger Institute - Genome Research Limited

Wellcome Trust Sanger Institute, Genome Research Limited
Genome Research Limited
CB10 1SA
United Kingdom


Dr. David Adams

principal investigator

Tel.: +44 122 349 68 62

Personal website

David Adams (PhD) is a group leader at the Wellcome Trust Sanger Institute. His research interests are the identification of cancer genes using experimental organisms, particularly mouse. He is head of the mouse genomes project.

Marcela PhD Sjoberg


I am fascinated by the diverse molecular mechanisms that have evolved to regulate the information encoded in the genome, which play an essential role in embryonic development and the maintenance of specialized cellular phenotypes. Cancer cells display significant alterations in their epigenome acquiring more plasticity and loosing part of the original identity. Moreover mutations in epigenetic modifiers have also emerged as recurrent events in cancer. However, the extent to which those mutations cooperate with other cancer related mutations and influence cancer development/progression requires further investigation.

Nicolas Walker